Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 6.74 is 116% above its 5-year average of 3.13, near the high end of its 5-year range (0.86–6.98).
As of the fiscal period ended Tuesday, June 30, 2026. 50.56% above its 12-month average of 4.48.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 6.74.
QUICK RATIO (ACID-TEST)
6.74
QUICK RATIO (ACID-TEST) AVG TTM
4.48
QUICK RATIO (ACID-TEST) AVG 3Y
4.17
QUICK RATIO (ACID-TEST) AVG 5Y
3.13
QUICK RATIO (ACID-TEST) AVG 10Y
2.25
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+50.56%
CURRENT VS 3Y AVG
+61.78%
CURRENT VS 5Y AVG
+115.76%
CURRENT VS 10Y AVG
+200.16%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.28
median of 795 covered companies
CURRENT VS SECTOR MEDIAN
+105.61%
vs the sector median at left
Aquestive Therapeutics, Inc.
Market Cap
$570.87M
Quick Ratio (Acid-Test)
6.74
TTM Avg
4.48
3Y Avg
4.17
5Y Avg
3.13
Market Cap
$564.81M
Quick Ratio (Acid-Test)
2.36
TTM Avg
2.55
3Y Avg
5.33
5Y Avg
7.55
Market Cap
$562.76M
Quick Ratio (Acid-Test)
9.36
TTM Avg
2.17
3Y Avg
1.76
5Y Avg
2.63
Market Cap
$560.00M
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$588.74M
Quick Ratio (Acid-Test)
6.18
TTM Avg
5.54
3Y Avg
6.26
5Y Avg
5.77
Market Cap
$588.44M
Quick Ratio (Acid-Test)
2.17
TTM Avg
3.09
3Y Avg
3.48
5Y Avg
3.24
Market Cap
$595.90M
Quick Ratio (Acid-Test)
6.06
TTM Avg
2.91
3Y Avg
9.30
5Y Avg
9.54
Market Cap
$543.14M
Quick Ratio (Acid-Test)
27.59
TTM Avg
10.29
3Y Avg
10.12
5Y Avg
12.12
Market Cap
$598.91M
Quick Ratio (Acid-Test)
1.49
TTM Avg
1.44
3Y Avg
1.41
5Y Avg
1.41
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | $570.87M | 6.74 | 4.48 | 4.17 | 3.13 |
| CorMedix Inc. (CRMD)vs › | $564.81M | 2.36 | 2.55 | 5.33 | 7.55 |
| CytomX Therapeutics, Inc. (CTMX)vs › | $562.76M | 9.36 | 2.17 | 1.76 | 2.63 |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| Fulgent Genetics, Inc. (FLGT)vs › | $588.74M | 6.18 | 5.54 | 6.26 | 5.77 |
| OrthoPediatrics Corp. (KIDS)vs › | $588.44M | 2.17 | 3.09 | 3.48 | 3.24 |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $595.90M | 6.06 | 2.91 | 9.30 | 9.54 |
| Shattuck Labs, Inc. (STTK)vs › | $543.14M | 27.59 | 10.29 | 10.12 | 12.12 |
| AngioDynamics, Inc. (ANGO)vs › | $598.91M | 1.49 | 1.44 | 1.41 | 1.41 |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $541.49M | 5.42 | 12.18 | 12.18 | 12.18 |
Quick Ratio
6.74
Excludes inventory
Current Ratio
7.19
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 6.74 |
| 2026-03-31 | 3.85 |
| 2025-12-31 | 3.01 |
| 2025-09-30 | 5.62 |
| 2025-06-30 | 3.18 |
| 2025-03-31 | 4.48 |
| 2024-12-31 | 4.36 |
| 2024-09-30 | 5.91 |
| 2024-06-30 | 6.98 |
| 2024-03-31 | 5.85 |
| 2023-12-31 | 1.87 |
| 2023-09-30 | 1.47 |
| 2023-06-30 | 0.88 |
| 2023-03-31 | 0.91 |
| 2022-12-31 | 0.86 |
| 2022-09-30 | 0.86 |
| 2022-06-30 | 1.30 |
| 2022-03-31 | 1.57 |
| 2021-12-31 | 1.97 |
| 2021-09-30 | 1.89 |
| 2021-06-30 | 2.09 |
| 2021-03-31 | 2.08 |
| 2020-12-31 | 2.00 |
| 2020-09-30 | 1.55 |
| 2020-06-30 | 2.74 |
| 2020-03-31 | 3.12 |
| 2019-12-31 | 3.53 |
| 2019-09-30 | 1.69 |
| 2019-06-30 | 1.40 |
| 2019-03-31 | 1.71 |
| 2018-12-31 | 2.09 |
| 2018-09-30 | 3.42 |
| 2018-06-30 | 0.95 |
| 2018-03-31 | 1.13 |
| 2017-12-31 | 1.57 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
